93 related articles for article (PubMed ID: 15310455)
1. USF1 implicated in the aetiology of familial combined hyperlipidaemia and the metabolic syndrome.
Shoulders CC; Naoumova RP
Trends Mol Med; 2004 Aug; 10(8):362-5. PubMed ID: 15310455
[TBL] [Abstract][Full Text] [Related]
2. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1).
Pajukanta P; Lilja HE; Sinsheimer JS; Cantor RM; Lusis AJ; Gentile M; Duan XJ; Soro-Paavonen A; Naukkarinen J; Saarela J; Laakso M; Ehnholm C; Taskinen MR; Peltonen L
Nat Genet; 2004 Apr; 36(4):371-6. PubMed ID: 14991056
[TBL] [Abstract][Full Text] [Related]
3. Genetics of familial combined hyperlipidemia.
Naukkarinen J; Ehnholm C; Peltonen L
Curr Opin Lipidol; 2006 Jun; 17(3):285-90. PubMed ID: 16680034
[TBL] [Abstract][Full Text] [Related]
4. USF1 on trial.
Shoulders CC
Nat Genet; 2004 Apr; 36(4):322-3. PubMed ID: 15054483
[No Abstract] [Full Text] [Related]
5. USF1 and dyslipidemias: converging evidence for a functional intronic variant.
Naukkarinen J; Gentile M; Soro-Paavonen A; Saarela J; Koistinen HA; Pajukanta P; Taskinen MR; Peltonen L
Hum Mol Genet; 2005 Sep; 14(17):2595-605. PubMed ID: 16076849
[TBL] [Abstract][Full Text] [Related]
6. Familial combined hyperlipidemia: upstream transcription factor 1 and beyond.
Lee JC; Lusis AJ; Pajukanta P
Curr Opin Lipidol; 2006 Apr; 17(2):101-9. PubMed ID: 16531745
[TBL] [Abstract][Full Text] [Related]
7. Familial combined hyperlipidemia in Mexicans: association with upstream transcription factor 1 and linkage on chromosome 16q24.1.
Huertas-Vazquez A; Aguilar-Salinas C; Lusis AJ; Cantor RM; Canizales-Quinteros S; Lee JC; Mariana-Nuñez L; Riba-Ramirez RM; Jokiaho A; Tusie-Luna T; Pajukanta P
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1985-91. PubMed ID: 15976322
[TBL] [Abstract][Full Text] [Related]
8. Upstream stimulatory factor (USF) as a transcriptional suppressor of human telomerase reverse transcriptase (hTERT) in oral cancer cells.
Chang JT; Yang HT; Wang TC; Cheng AJ
Mol Carcinog; 2005 Nov; 44(3):183-92. PubMed ID: 16010690
[TBL] [Abstract][Full Text] [Related]
9. [Disorder of lipid metabolism in visceral fat syndrome--relation to familial combined hyperlipidemia].
Ishigami M; Nakamura T; Matsuzawa Y
Nihon Rinsho; 2002 May; 60(5):868-74. PubMed ID: 12029987
[TBL] [Abstract][Full Text] [Related]
10. Relationship between familial combined hyperlipidemia and insulin resistance.
Jackuliaková D; Vaverková H; Karásek D
Vnitr Lek; 2008 Nov; 54(11):1045-53. PubMed ID: 19069677
[TBL] [Abstract][Full Text] [Related]
11. Role of USF1 and USF2 as potential repressor proteins for human intestinal monocarboxylate transporter 1 promoter.
Hadjiagapiou C; Borthakur A; Dahdal RY; Gill RK; Malakooti J; Ramaswamy K; Dudeja PK
Am J Physiol Gastrointest Liver Physiol; 2005 Jun; 288(6):G1118-26. PubMed ID: 15691871
[TBL] [Abstract][Full Text] [Related]
12. Upstream transcription factor 1 influences plasma lipid and metabolic traits in mice.
Wu S; Mar-Heyming R; Dugum EZ; Kolaitis NA; Qi H; Pajukanta P; Castellani LW; Lusis AJ; Drake TA
Hum Mol Genet; 2010 Feb; 19(4):597-608. PubMed ID: 19995791
[TBL] [Abstract][Full Text] [Related]
13. Associations between USF1 gene variants and cardiovascular risk factors in the Quebec Family Study.
Choquette AC; Bouchard L; Houde A; Bouchard C; Pérusse L; Vohl MC
Clin Genet; 2007 Mar; 71(3):245-53. PubMed ID: 17309647
[TBL] [Abstract][Full Text] [Related]
14. Role of bile acids and bile acid receptors in metabolic regulation.
Lefebvre P; Cariou B; Lien F; Kuipers F; Staels B
Physiol Rev; 2009 Jan; 89(1):147-91. PubMed ID: 19126757
[TBL] [Abstract][Full Text] [Related]
15. Potential regulatory role of the farnesoid X receptor in the metabolic syndrome.
Duran-Sandoval D; Cariou B; Fruchart JC; Staels B
Biochimie; 2005 Jan; 87(1):93-8. PubMed ID: 15733743
[TBL] [Abstract][Full Text] [Related]
16. Unraveling the complex genetics of familial combined hyperlipidemia.
Suviolahti E; Lilja HE; Pajukanta P
Ann Med; 2006; 38(5):337-51. PubMed ID: 16938803
[TBL] [Abstract][Full Text] [Related]
17. Cooperative activation of lipocalin-type prostaglandin D synthase gene expression by activator protein-2beta in proximal promoter and upstream stimulatory factor 1 within intron 4 in human brain-derived TE671 cells.
Fujimori K; Urade Y
Gene; 2007 Aug; 397(1-2):143-52. PubMed ID: 17574780
[TBL] [Abstract][Full Text] [Related]
18. Roles for USF-2 in lung cancer proliferation and bronchial carcinogenesis.
Ocejo-Garcia M; Baokbah TA; Ashurst HL; Cowlishaw D; Soomro I; Coulson JM; Woll PJ
J Pathol; 2005 Jun; 206(2):151-9. PubMed ID: 15856526
[TBL] [Abstract][Full Text] [Related]
19. FXR: a promising target for the metabolic syndrome?
Cariou B; Staels B
Trends Pharmacol Sci; 2007 May; 28(5):236-43. PubMed ID: 17412431
[TBL] [Abstract][Full Text] [Related]
20. The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism.
Claudel T; Staels B; Kuipers F
Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2020-30. PubMed ID: 16037564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
